Publications and Research Results
Publications
The NDB reports to the rheumatology community in peer reviewed journals.
Posters and Slide Presentations
The NDB shares research results in poster and slide presentations at the major scientific
rheumatology meetings.
These documents are avaiable in links away from this site, or in Microsoft PowerPoint,
Word, or Adobe PDF file format. Please contact us if you need another format.
Posters and Slide Presentations
2007
- Effect of Anti-TNF Therapy and Corticosteroids on the Risk of Stroke in Patients with Rheumatoid Arthritis(EULAR 2007)
2006
- The Use of Biologic Therapy in Patients with RA and Existing Cancer (ACR 2006)
- Resistance to Changing Therapy: Discordance Between RA Activity and Patients’ Treatment Choices (ACR 2006)
- The Association of Fibromyalgia Symptoms with SLE Outcome and Diagnosis (ACR 2006)
- Economic Inequalities and Reduced Quality of Life in Patients with Osteoarthritis and Fibromyalgia (ACR 2006)
- Longitudinal Changes in Quality of Life in Rheumatoid Arthritis Compared With a Healthy US National Sample(ACR 2006)
- RA Outcomes in Patients Not Meeting Severity Criteria for Biologic Prescription (ACR 2006)
- Trends in Medication Use by 10,982 Community Rheumatoid Arthritis Patients in the United States from 1998 to 2005: Biologic Use Now at 40% (EULAR 2006)
- Lymphoma Risk in Rheumatoid Arthritis in the US: No Association with Anti-TNF Therapy (EULAR 2006)
2005
- Rheumatoid Arthritis, Medical Costs, Access to Care and the Outcome of Illness (ACR 2005)
- Prevalence and Characteristics of Anemia in Patients with Rheumatoid Arthritis (RA) (ACR 2005)
- Breast Cancer in RA: No Effect of Anti-Rheumatic Therapy (ACR 2005)
- Combination Therapy and the Outcome of Rheumatoid Arthritis (RA) (ACR 2005)
- Duration of DMARD and Biologic Therapies: Switching Behavior and Predictors of Discontinuation (ACR 2005)
- The Risk of Fibromyalgia Development: Rates and Risk Factors (ACR 2005)
- How Shall Fibromyalgia Be Diagnosed? A Comparison of Clinical, Survey and ACR Criteria (ACR 2005)
- Usefulness of A Visual Analog Function Scale in RA Clinical Trials: Increased Sensitivity Compared with Conventional Measures (ACR 2005)
- Rates of GI Bleeding and Perforated Ulcers, and Changing Patterns of Risk Factors (ACR 2005)
- The incidence of lung cancer in RA: No association with RA after adjustment for non-RA factors (ACR 2005)
- Longitudinal Assessment of Pain in RA: MCID, Predictors & the Effect of Anti-TNF Therapy (ACR 2005)
- Once on Prednisone Always on Prednisone? Rates and Reasons for Prednisone Initiation and Discontinuation (ACR 2005)
- Can Severity Be Predicted by Treatment Variables In RA Administrative Data Bases? (ACR 2005)
- The Symptom Intensity (SI) Scale, Fibromyalgia and the Meaning of Fibromyalgia-like Symptoms (ACR 2005)
- Infliximab Improves all Components of Physical Function Assessed by the HAQ in Patients with Rheumatoid Arthritis: Results from START Clinical Trial (ACR 2005)
- An Effective Measure of Treatment Efficacy: The VAS Stiffness Severity Scale: Results from the Humira Efficacy Response Optimization (HERO) Trial (ACR 2005)
2004
-
Jaw Pain: Characteristics and Prevalence in Fibromyalgia and other Rheumatic Disorders
(ACR 2004)
-
Corticosteroid Therapy is Associated with Serious Side Effects Over a Broad Spectrum of Outcomes: Results from a Large Longitudinal Study
(ACR 2004)
-
Anti-TNF Therapy and the Risk of Joint Infection in Patients with Rheumatoid Arthritis
(ACR 2004)
-
Factors Related to Proton Pump Inhibitor (PPI) Prescription: COX-2 and NSAID Therapy Both Predict PPI Prescription
(ACR 2004)
-
Safety Data Comparing Combination Therapy of Leflunomide plus Methotrexate to Leflunomide Alone: A Five-Year Prospective Study
(ACR 2004)
-
The Effect of Low Dose Aspirin on the Risk of Development of
Dyspepsia and Gastrointestinal Ulcers
(ACR 2004)
-
Prednisone Use and the Risk of Cataract Formation in Persons with Rheumatoid Arthritis
(ACR 2004)
-
Rates of Gastrointestinal Prophylactic Therapy Among Arthritis Patients with Risk Factors for Peptic Ulcer
(ACR 2004)
-
Retardation of Disability by Anti-TNF Therapy: Results of a 5 Year Study of 3900 RA Patients
(ACR 2004)
-
Sinus Disorders in Rheumatoid Arthritis: Prevalence and Treatment Effects (ACR 2004)
-
Incidence of Skin Cancer in Rheumatoid Arthritis (ACR 2004)
-
Somatization and its Discontents: Rates, Predictors and Correlates
of Somatic Symptoms in Rheumatic Disease Patients (ACR 2004)
-
Statins and Physical Function Among 6,265 Patients
with Rheumatoid Arthritis (ACR 2004)
-
Anti-Tumor Necrosis Factor Therapy with Infliximab Decreases the Risk of Stroke in Patients with Rheumatoid Arthritis (ACR 2004)
2003
-
The changing face
of ulcer disease (ACR 2003)
-
NDB Infliximab
dose (ACR 2003)
-
Productivity and
sleep disturbance (ACR 2003)
-
HAQ-based Utilities
and SF6D Systematically Overvalue Quality of Life (QOL) in RA
Patients with Severe RA, Pain and Psychological Distress (ACR
2003)
-
Publications...
